Literature DB >> 9149162

Midline glossectomy and epiglottidectomy for obstructive sleep apnea syndrome.

S A Mickelson1, L Rosenthal.   

Abstract

Obstructive sleep apnea syndrome is caused by narrowing of the pharyngeal airway and loss of dilator tone during sleep. In patients with severe apnea surgical correction often requires attention to both the oropharynx and hypopharynx. Tongue reduction surgery has been described for persistent apnea after failure of palatal surgery. We describe our experience with midline glossectomy with epiglottidectomy in 12 patients with a mean age of 48.8 +/- 14.2 years and body mass index of 36.0 +/- 8.8 kg/m2. Response to treatment was defined as a postoperative respiratory disturbance index (RDI) below 20. Three patients (25%) responded to treatment. The mean apnea index decreased from 48.9 to 35.7, RDI decreased from 73.3 to 46.6, and lowest oxygen saturation increased from 65.9 to 77.9%. RDI in responders decreased from 69.7 to 10. Midline glossectomy with epiglottidectomy has variable results, yet is effective in selected patients with hypopharyngeal narrowing related to macroglossia.

Entities:  

Mesh:

Year:  1997        PMID: 9149162     DOI: 10.1097/00005537-199705000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  15 in total

1.  [Guideline: Treatment of obstructive sleep apnea in adults].

Authors:  T Verse; R Bodlaj; R de la Chaux; A Dreher; C Heiser; M Herzog; W Hohenhorst; K Hörmann; O Kaschke; T Kühnel; N Mahl; J T Maurer; W Pirsig; K Rohde; A Sauter; M Schedler; R Siegert; A Steffen; B A Stuck
Journal:  HNO       Date:  2009-11       Impact factor: 1.284

2.  [S2e-guideline: "ENT-specific therapy of obstructive sleep apnea in adults" short version : Sleep Medicine Task Force of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  T Verse; A Dreher; C Heiser; M Herzog; J T Maurer; W Pirsig; K Rohde; N Rothmeier; A Sauter; A Steffen; S Wenzel; B A Stuck
Journal:  HNO       Date:  2016-05       Impact factor: 1.284

3.  ENT-specific therapy of obstructive sleep apnoea in adults : A revised version of the previously published German S2e guideline.

Authors:  T Verse; A Dreher; C Heiser; M Herzog; J T Maurer; W Pirsig; K Rohde; N Rothmeier; A Sauter; A Steffen; S Wenzel; B A Stuck
Journal:  Sleep Breath       Date:  2016-05-14       Impact factor: 2.816

4.  Safety of cold ablation (coblation) in the treatment of tonsillar hypertrophy of the tongue base.

Authors:  Sarah Ulrike Leitzbach; Robert Bodlaj; Joachim Theodor Maurer; Karl Hörmann; Boris Alexander Stuck
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-08       Impact factor: 2.503

5.  Swallowing outcome after TORS for sleep apnea: short- and long-term evaluation.

Authors:  Mohamed Eesa; Filippo Montevecchi; Ehsan Hendawy; Giovanni D'Agostino; Giuseppe Meccariello; Claudio Vicini
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-04       Impact factor: 2.503

6.  Transcervical tongue base reduction with hyoepiglottoplasty: long-term results.

Authors:  Meltem Esen Akpinar; Berk Gurpinar; Mazhar Celikoyar; Ismail Kocak
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-02-10

Review 7.  The surgical treatment of sleep-related upper airway obstruction.

Authors:  Thomas Verse; Karl Hörmann
Journal:  Dtsch Arztebl Int       Date:  2011-04-01       Impact factor: 5.594

Review 8.  Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis.

Authors:  Sean M Caples; James A Rowley; Jeffrey R Prinsell; John F Pallanch; Mohamed B Elamin; Sheri G Katz; John D Harwick
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

9.  Maxillomandibular Advancement (MMA) in a Site-Specific Treatment Approach for Obstructive Sleep Apnea: A Surgical Algorithm.

Authors:  Jeffrey R. Prinsell
Journal:  Sleep Breath       Date:  2000       Impact factor: 2.816

10.  Contemporary surgery for obstructive sleep apnea syndrome.

Authors:  Nelson B Powell
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-09-23       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.